A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry.
about
Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometryFever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E212-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptorTargeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry.Relief from neuropathic pain by blocking of the platelet-activating factor-pain loopClostridium difficile toxin B differentially affects GPCR-stimulated Ca2+ responses in macrophages: independent roles for Rho and PLA2.Rapid production of platelet-activating factor is induced by protein kinase Cα-mediated phosphorylation of lysophosphatidylcholine acyltransferase 2 proteinImproved sensitivity mass spectrometric detection of eicosanoids by charge reversal derivatizationThromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand.Mouse and human neutrophils induce anaphylaxis.Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient miceFatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport.Human FcγRIIA induces anaphylactic and allergic reactions.Lung function and biomarkers of airway inflammation during and after hospitalization for acute exacerbations of childhood asthma associated with viral respiratory symptomsImportance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model.Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor.Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitisFacile preparation of leukotrienes C(4), D(4) and E(4) containing carbon-13 and nitrogen-15 for quantification of cysteinyl leukotrienes by mass spectrometry.UPLC-MS/MS-Based Profiling of Eicosanoids in RAW264.7 Cells Treated with LipopolysaccharideQuantification of fatty acid oxidation products using online high-performance liquid chromatography tandem mass spectrometry.Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators.Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis.Intravenous anesthetic propofol binds to 5-lipoxygenase and attenuates leukotriene B4 production.Isotope-dilution UPLC-MS/MS determination of cell-secreted bioactive lipids.Arachidonate-derived dihomoprostaglandin production observed in endotoxin-stimulated macrophage-like cells.Leukotriene B4 augments and restores Fc gammaRs-dependent phagocytosis in macrophages.Basophil activation through ASGM1 stimulation triggers PAF release and anaphylaxis-like shock in mice.Pharmacokinetic characteristics of a vasodilatory and antiplatelet agent, limaprost alfadex, in the healthy Korean volunteers.A new methodology for simultaneous quantification of total-Aβ, Aβx-38, Aβx-40, and Aβx-42 by column-switching LC/MS/MS.Orchestrating Role of Apoptosis Inhibitor of Macrophage in the Resolution of Acute Lung Injury.Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 and COX-2.Spatiotemporal alteration of phospholipids and prostaglandins in a rat model of spinal cord injury.
P2860
Q28397076-73B3F236-3A37-40D9-A7FE-028152DEB793Q28546726-1FF4AE3C-153A-4807-AA9B-5B3C8D110389Q30579732-DA6DF77D-D4F9-4569-8742-3CDB7821333AQ33442367-3B4E42C4-68D3-4F54-817B-E58B955A3544Q33800609-63CC990F-1E08-4E3E-B0F1-5D49D0D7C031Q33860004-EA52F75D-ADA3-4AEE-849A-1725F2AF78E5Q34075985-FFEBC2BC-639B-416C-938F-6F1BB3B9DD25Q34222155-AB363454-4A30-4311-A007-EE37DAA8E2F1Q34368967-888B4B7D-EA46-4F31-B319-0CB355733A24Q34755391-5EFE0A01-786A-4B57-A1B7-4A4EDDC6F879Q35088319-450FF6FD-15E0-4196-AC14-082E23E0CC49Q35621848-EC06B992-2F04-4320-B8A8-5EA7749DA1E4Q35849322-D562EE27-225A-464B-96DA-2CEEC0FF4991Q36198171-D930FBB3-0A0A-4767-9639-4328ED93D417Q36229287-06800E26-A86A-4AFE-BDBA-8605D988DDA2Q36403038-CCC84E96-77F2-4858-B338-0DEA1B1C9527Q36497015-10B16FE8-D3DD-4756-8BFB-FD2808B69FB9Q36688837-E7537DE8-7569-46B4-85BC-41B3A8A25BFFQ36847053-CAA0D6B6-F249-45B8-A861-ACD9FDE81FF7Q37169596-B609D355-CE60-4B02-955B-6801C7A34B8BQ37402769-3FF9F002-207E-4E94-878F-BEE98CCC8477Q37463199-97072AA8-6061-4CEF-A14B-ECA685CBAF2DQ38772584-32493107-46FB-48AE-A451-9373BA00D528Q39113995-93D145FD-A0A6-42F0-A840-D86EE8C1E844Q40202967-0272D20F-86F5-481E-A3D9-CA539BBC77F9Q41198602-2EB9F1C5-C2E7-407D-8495-D73B796870DAQ42221679-1E7B8017-8D4D-4A6F-A532-91E3A9D4692DQ43262212-FD308E18-6CB7-44E5-B029-C571EFC4960BQ45919254-B738723D-F07A-4A34-96A2-48BB797B64B2Q47603298-FCED92D2-E1D6-4D21-A5E1-4F3058775604Q48602031-C1ECE064-89AA-4ECB-BE72-0F08DBFAC701Q48616515-581491C6-FC37-4ACB-BD2B-90DB4230F8DC
P2860
A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A multiplex quantitation metho ...... aphy-tandem mass spectrometry.
@en
type
label
A multiplex quantitation metho ...... aphy-tandem mass spectrometry.
@en
prefLabel
A multiplex quantitation metho ...... aphy-tandem mass spectrometry.
@en
P2093
P356
P1476
A multiplex quantitation metho ...... aphy-tandem mass spectrometry.
@en
P2093
Naonori Uozumi
Takao Shimizu
Toshie Takahashi
Yoshihiro Kita
P304
P356
10.1016/J.AB.2005.03.048
P407
P577
2005-07-01T00:00:00Z